Is the Venom of Some Snakes Used in Medicines?
Question by mits4u2005: Is the venom of some snakes used in medicines?
Best answer:
Answer by garfyldrox
COBRA
Heart Patients May Have New Medicinal Snake Blood thinner from venom should be safer, easier to use
Coumadin, the popular but troublesome blood thinner, may soon have to make way for a new drug that seems to work more predictably and safely. Patients will have researchers to thank, along with a not-quite-usual suspect: the cobra.
The drug, derived from cobra venom, is expected to reach pharmacies within 18 months under the brand name Exanta.
Its manufacturer announced last week it has submitted the drug to the U.S. Food and Drug Administration (FDA) for approval.
Experts say the drug could save time and reduce risks for millions of patients who face potential heart attacks and stroke.
“It would bring a dramatic change to how cardiologists practice,” says Dr. Jonathan Halperin, a professor of medicine at Mount Sinai Medical Center in New York City. “This would be an important step forward if the drug is safe and available.”
Coumadin, also known by the generic name warfarin, has been on the market for almost 60 years. It thins the blood, reducing the likelihood of blood clots that can block arteries and contribute to stroke or heart attack.
The drug is often a second line of defense after aspirin, which prevents blood clots in a different way and is not as powerful.
But taking Coumadin is not as simple as just popping pills. “The problem with warfarin is that everybody absorbs it a little differently.
People have to have frequent blood monitoring to adjust the dose,” says Dr. Howard Herrmann, director of cardiac catheterization and interventional cardiology at the University of Pennsylvania.
The blood tests are typically required at least once a month. If patients and doctors don’t work together to keep an eye on the levels of Coumadin in the body, the blood can become too thin (raising the risk of internal bleeding or hemorrhaging after an accident) or too thick (raising the risk of a clot).
Since Coumadin works by interfering with the body’s absorption of vitamin K from food, even a minor change in a person’s normal diet can disrupt Coumadin levels.
To make matters more complicated, Coumadin interacts with a variety of drugs, making them work improperly or vice versa. “Antibiotics are frequent offenders, as are drugs used to control high cholesterol,” Halperin says. “There are hundreds if not thousands of drugs. The list alone goes on for five pages.”
Essentially, Halperin says, “a more effective anticoagulant is needed,” especially for patients for whom aspirin isn’t sufficient.
Here’s where Exanta, also known as ximelagatran, comes in. It’s derived from the venom of the cobra, which seems to render victims powerless by thinning their blood.
While it has not received federal approval yet, recent studies have reported the drug manages to thin the blood at a steady level without major fluctuations, unlike Coumadin. Patients wouldn’t need to undergo regular blood tests to check the thinness of their blood.
“It’s given in a fixed dose, and has no significant food or drug interactions,” says Halperin. “It’s almost like one-size-fits-all.”
The drug’s manufacturer, AstraZeneca, is seeking FDA approval to offer the drug as a treatment for people with atrial fibrillation (a potentially dangerous irregular heartbeat) and others at risk of blood clots.
Experts caution however, that while Exanta may be a great improvement upon Coumadin, it won’t be perfect. The drug appears to affect liver enzymes in about 6 percent of patients, although they did fine later, Halperin says.
“It will be appropriate that people who begin should have certain blood tests taken from time to time to make sure they and the medicine are getting along well with one another,” Halperin says.
Then there’s the matter of cost. New drugs, not surprisingly, typically cost much more than drugs that are a half-century old. But experts say doctors will save time by not having to order and review monthly blood tests.
More cost savings could come if fewer people have strokes because Exanta is easier to use than Coumadin.
According to the manufacturer of Exanta, studies have shown blood thinners reduce the incidence of stroke by 62 percent in patients at risk, but only half of them get the optimal treatment.
On the whole, Halperin says, “there’s a good chance that a drug like this could replace warfarin for most people.”
PIT VIPER SNAKE
Experimental Drug Derived From Snake Venom Shows Promise In Reversing Effects Of Stroke
NASHVILLE, Feb. 4 — A stroke therapy derived from snake venom? According to researchers, it’s not a snake oil story, but instead a possible new way to help people recover from the devastating effects of stroke
ANCROD is derived from the venom of a pit viper snake. Researchers discovered that in people who were bitten by the snake, blood failed to clot. Based on that observation, the venom was utilized as an anticoagulant, helping blood flow more freely through vessels.
Know better? Leave your own answer in the comments!
Philadelphia PA Drug Rehab Call (888) 321-1718 Drug Rehab Center Philadelphia Pennsylvania – Call 888-321-1718 for help anytime http://drugrehabscenter.org/ Picking the right rehab center for your recovery. The place of a drug rehab center certainly …
Vets courts gain support
Filed under: drug treatment centers in pennsylvania
The veterans courts are designed to handle nonviolent offenders who have completed military service and whose crimes are influenced by mental illness or addiction. Charges are dismissed or … Pennsylvania is home to 953,000 veterans – the fourth …
Read more on The Tribune-Democrat
Heroin addicts seeking sobriety face barriers to receiving treatment
Filed under: drug treatment centers in pennsylvania
NEW YORK (AP) — As the ranks of heroin users rise, increasing numbers of addicts are looking for help but are failing to find it — because there are no beds in packed facilities, treatment is hugely expensive and insurance companies won't pay for …
Read more on The Patriot-News
28th Senate Q&A: Zack Hearn, Linda Small and Scott Wagner
Filed under: drug treatment centers in pennsylvania
But analysts and groups such as the Pennsylvania Budget and Policy Center estimate the impact fee generates less revenue than a severance tax. …. For parents with children suffering from certain medical conditions that some or all symptoms could be …
Read more on York Dispatch
169th House Q&A: Kate Klunk, Gene Montanerelli, Leroy Wentz and Marc Woerner
Filed under: drug treatment centers in pennsylvania
But analysts and groups such as the Pennsylvania Budget and Policy Center estimate the impact fee generates less revenue than a severance tax. Should natural gas drillers …. Before supporting legalization of marijuana for certain medical purposes, I …
Read more on York Dispatch